Home/Axonis Therapeutics/Shane V. Hegarty, Ph.D.
SV

Shane V. Hegarty, Ph.D.

Chief Scientific Officer & Co-Founder

Axonis Therapeutics

Therapeutic Areas

Axonis Therapeutics Pipeline

DrugIndicationPhase
AXN-027Epilepsy, Pain, and other CNS pathologiesPhase 1